---
title: "LATS1 as a context-specific regulator in melanoma: preprint reports a zebrafish lats1 knockout mod"
id: "biorxiv-0-integrative-analysis-identifies-lats1-as-a-context-specific-regulator-of"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-0-integrative-analysis-identifies-lats1-as-a-context-specific-regulator-of"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1?rss=1"
published_at: "2026-11-16T11:50:08.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# LATS1 as a context-specific regulator in melanoma: preprint reports a zebrafish lats1 knockout mod
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-0-integrative-analysis-identifies-lats1-as-a-context-specific-regulator-of
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1?rss=1)
- **Published At:** 2026-11-16T11:50:08.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Malignant **melanoma** incidence is rising and metastatic disease carries poor survival; the preprint frames this clinical challenge in oncology. - The principal oncogenic drivers in melanoma are **BRAF** and **NRAS**; targeted agents and immunotherapies improved outcomes for patients with **BRAF**-mutant disease. - The authors note an absence of approved targeted therapies for **NRAS**-mutant melanoma and emphasize that therapeutic resistance remains a persistent problem. - Prior studies have implicated deregulation of the **MST2/Hippo** signalling axis in melanoma biology; the core kinase **LATS1** sits at a signalling hub linking cell death and proliferation. - The preprint states that **LATS1** inactivation has been associated with melanoma progression and resistance to targeted therapies, but the precise mechanisms remain unresolved. - To probe **LATS1** function, the investigators developed a **lats1** knockout zebrafish melanoma model driven by either **BRAF** or **NRAS**; the source document provides no further experimental results in the excerpt provided. - The paper is a preprint and has not undergone peer review; the abstract text available here does not report specific methods, quantitative outcomes, or downstream immune-response data. - Key unanswered items in the accessible excerpt include experimental design details, phenotypic readouts, immune profiling results, and any therapeutic or mechanistic conclusions the authors may have drawn. - Readers should consult the full preprint for complete datasets; based on the excerpt, the study aims to clarify how **LATS1** modulates melanoma progression and the tumour immune environment.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Integrative analysis identifies LATS1 as a context-specific regulator of melanoma progression and immune response Nourhan Aboud, Donagh Egan, Andrew P Badrock, Pamela Kelly, Susan Peters, Brian Cloak, Kieran Wynne, Elena Merino Tejero, Sabina Susanu, Elaine O'Boyle, Luis Iglesias Martínez, Walter Kolch, Melinda Halasz, Adam Hurlstone, [ View ORCID Profile](http://orcid.org/0000-0003-4396-4814)Lucía García-Gutiérrez, [ View ORCID Profile](http://orcid.org/0000-0002-2360-3141)David Matallanas doi: https://doi.org/10.64898/2026.11.12.766289 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Nourhan Aboud 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nourhan%2BAboud%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Aboud%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ANourhan%2BAboud%2B) Donagh Egan 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Donagh%2BEgan%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Egan%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADonagh%2BEgan%2B) Andrew P Badrock 2 Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andrew%2BP%2BBadrock%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Badrock%20AP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAndrew%2BP%2BBadrock%2B) Pamela Kelly 3 UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pamela%2BKelly%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kelly%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APamela%2BKelly%2B) Susan Peters 3 UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Susan%2BPeters%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Peters%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASusan%2BPeters%2B) Brian Cloak 3 UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Brian%2BCloak%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Cloak%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ABrian%2BCloak%2B) Kieran Wynne 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kieran%2BWynne%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Wynne%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AKieran%2BWynne%2B) Elena Merino Tejero 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elena%2BMerino%2BTejero%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Merino%20Tejero%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AElena%2BMerino%2BTejero%2B) Sabina Susanu 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sabina%2BSusanu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Susanu%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASabina%2BSusanu%2B) Elaine O'Boyle 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elaine%2BO%27Boyle%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=O%27Boyle%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AElaine%2BO%2527Boyle%2B) Luis Iglesias Martínez 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Luis%2BIglesias%2BMart%C3%ADnez%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Iglesias%20Mart%C3%ADnez%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALuis%2BIglesias%2BMart%25C3%25ADnez%2B) Walter Kolch 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Walter%2BKolch%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kolch%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AWalter%2BKolch%2B) Melinda Halasz 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Melinda%2BHalasz%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Halasz%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMelinda%2BHalasz%2B) Adam Hurlstone 4 Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Adam%2BHurlstone%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hurlstone%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAdam%2BHurlstone%2B) Lucía García-Gutiérrez 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Luc%C3%ADa%2BGarc%C3%ADa-Guti%C3%A9rrez%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Garc%C3%ADa-Guti%C3%A9rrez%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALuc%25C3%25ADa%2BGarc%25C3%25ADa-Guti%25C3%25A9rrez%2B) * [ORCID record for Lucía García-Gutiérrez](http://orcid.org/0000-0003-4396-4814 "Open in new tab") David Matallanas 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield Dublin 4, Ireland; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=David%2BMatallanas%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Matallanas%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADavid%2BMatallanas%2B) * [ORCID record for David Matallanas](http://orcid.org/0000-0002-2360-3141 "Open in new tab") * For correspondence: david.gomez@ucd.ie * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5965262/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5965262/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5965262/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.12.766289v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5965262/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Malignant melanoma incidence is increasing, and survival remains poor following metastasis. The main driver oncogenes are BRAF and NRAS. Advancements in targeted agents and immunotherapies have improved survival rates, especially for patients with BRAF mutant melanoma. However, no targeted therapy options are available for patients with NRAS-mutant melanoma. Unfortunately, the development of resistance to all existing therapies remains a challenge. Recent evidence has shown that the MST2/Hippo pathway is deregulated in melanoma. The MST2 pathway core kinase LATS1 is a signalling hub that mediates the crosstalk between cell death and proliferation networks, and its inactivation has been related to melanoma progression and resistance to targeted therapy. However, the mechanisms by which LATS1 influences melanoma biology remain unclear. Here, to investigate this role of LATS1, we developed a lats1 knockout zebrafish melanoma model driven by either BRAF or NRA
## Related Clinical Research

- [Continuous karyotypic instability and structural flux in acral melanoma genomes](https://medichelpline.com/clinical-feed/biorxiv-0-continuous-karyotypic-and-cryptic-structural-fluctuations-drive-acral-melanoma.md)
- [3D Bioprinted Human Skin Melanoma Model for High-Throughput Drug Screening](https://medichelpline.com/clinical-feed/biorxiv-2-a-three-dimensional-bioprinted-skin-melanoma-model-for-high-throughput-drug.md)
- [Dual immune checkpoint inhibition for melanoma brain metastases: safety and efficacy meta-analysis](https://medichelpline.com/clinical-feed/pubmed-42934318.md) (DOI: 10.1007/s10143-026-04538-w)
- [State Tanning Bed Availability Linked to Higher Early-Onset Melanoma in Midwest and South](https://medichelpline.com/clinical-feed/medrxiv-1-state-tanning-bed-availability-is-associated-with-early-onset-melanoma.md)
- [Personalized mRNA vaccine plus pembrolizumab lowers melanoma recurrence in phase 3 trial](https://medichelpline.com/clinical-feed/medical-news-today-0-novel-mrna-vaccine-plus-immunotherapy-reduces-melanoma-relapse-in-phase-3-trial.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.